nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicoumarol—NQO1—Parkinson's disease	0.852	1	CbGaD
Dicoumarol—GPR35—head—Parkinson's disease	0.00637	0.0838	CbGeAlD
Dicoumarol—GPR35—nervous system—Parkinson's disease	0.00604	0.0794	CbGeAlD
Dicoumarol—GPR35—central nervous system—Parkinson's disease	0.00581	0.0765	CbGeAlD
Dicoumarol—NQO1—Dopamine metabolism—DDC—Parkinson's disease	0.00496	0.0692	CbGpPWpGaD
Dicoumarol—CRYZ—embryo—Parkinson's disease	0.00469	0.0616	CbGeAlD
Dicoumarol—GPR35—brain—Parkinson's disease	0.00461	0.0607	CbGeAlD
Dicoumarol—GPR35—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.00452	0.063	CbGpPWpGaD
Dicoumarol—NQO1—Dopamine metabolism—MAOB—Parkinson's disease	0.00417	0.0582	CbGpPWpGaD
Dicoumarol—CRYZ—forebrain—Parkinson's disease	0.00414	0.0545	CbGeAlD
Dicoumarol—CRYZ—cardiovascular system—Parkinson's disease	0.0035	0.0461	CbGeAlD
Dicoumarol—CRYZ—medulla oblongata—Parkinson's disease	0.00299	0.0394	CbGeAlD
Dicoumarol—NQO1—Dopamine metabolism—TH—Parkinson's disease	0.00277	0.0386	CbGpPWpGaD
Dicoumarol—CRYZ—midbrain—Parkinson's disease	0.00274	0.036	CbGeAlD
Dicoumarol—CRYZ—spinal cord—Parkinson's disease	0.00267	0.0351	CbGeAlD
Dicoumarol—VKORC1—cardiovascular system—Parkinson's disease	0.00241	0.0317	CbGeAlD
Dicoumarol—NQO1—Dopamine metabolism—SOD1—Parkinson's disease	0.0024	0.0335	CbGpPWpGaD
Dicoumarol—CRYZ—head—Parkinson's disease	0.00237	0.0312	CbGeAlD
Dicoumarol—NQO1—Dopamine metabolism—COMT—Parkinson's disease	0.00235	0.0328	CbGpPWpGaD
Dicoumarol—NQO1—Dopamine metabolism—MAOA—Parkinson's disease	0.00233	0.0326	CbGpPWpGaD
Dicoumarol—CRYZ—nervous system—Parkinson's disease	0.00225	0.0296	CbGeAlD
Dicoumarol—CRYZ—central nervous system—Parkinson's disease	0.00217	0.0285	CbGeAlD
Dicoumarol—CRYZ—cerebellum—Parkinson's disease	0.00212	0.0278	CbGeAlD
Dicoumarol—GPR35—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.0021	0.0294	CbGpPWpGaD
Dicoumarol—NQO1—Transcriptional activation by NRF2—HMOX1—Parkinson's disease	0.00206	0.0287	CbGpPWpGaD
Dicoumarol—GPR35—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.00183	0.0255	CbGpPWpGaD
Dicoumarol—NQO1—Estrogen metabolism—COMT—Parkinson's disease	0.00181	0.0253	CbGpPWpGaD
Dicoumarol—NQO1—forebrain—Parkinson's disease	0.00177	0.0233	CbGeAlD
Dicoumarol—GPR35—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.00176	0.0246	CbGpPWpGaD
Dicoumarol—CRYZ—brain—Parkinson's disease	0.00172	0.0226	CbGeAlD
Dicoumarol—GPR35—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00171	0.0238	CbGpPWpGaD
Dicoumarol—NQO1—Estrogen metabolism—GSTM1—Parkinson's disease	0.00166	0.0231	CbGpPWpGaD
Dicoumarol—VKORC1—head—Parkinson's disease	0.00163	0.0215	CbGeAlD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—VIM—Parkinson's disease	0.00156	0.0218	CbGpPWpGaD
Dicoumarol—VKORC1—nervous system—Parkinson's disease	0.00155	0.0204	CbGeAlD
Dicoumarol—GPR35—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00154	0.0216	CbGpPWpGaD
Dicoumarol—GPR35—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00154	0.0216	CbGpPWpGaD
Dicoumarol—NQO1—cardiovascular system—Parkinson's disease	0.0015	0.0197	CbGeAlD
Dicoumarol—VKORC1—central nervous system—Parkinson's disease	0.00149	0.0196	CbGeAlD
Dicoumarol—VKORC1—cerebellum—Parkinson's disease	0.00146	0.0192	CbGeAlD
Dicoumarol—NQO1—medulla oblongata—Parkinson's disease	0.00128	0.0168	CbGeAlD
Dicoumarol—NQO1—Oxidative Stress—SOD1—Parkinson's disease	0.00123	0.0171	CbGpPWpGaD
Dicoumarol—NQO1—Oxidative Stress—MAOA—Parkinson's disease	0.0012	0.0167	CbGpPWpGaD
Dicoumarol—VKORC1—brain—Parkinson's disease	0.00118	0.0156	CbGeAlD
Dicoumarol—NQO1—Oxidative Stress—HMOX1—Parkinson's disease	0.00118	0.0165	CbGpPWpGaD
Dicoumarol—NQO1—midbrain—Parkinson's disease	0.00117	0.0154	CbGeAlD
Dicoumarol—NQO1—spinal cord—Parkinson's disease	0.00114	0.015	CbGeAlD
Dicoumarol—NQO1—Oxidative Stress—SOD2—Parkinson's disease	0.00111	0.0154	CbGpPWpGaD
Dicoumarol—GPR35—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00108	0.0151	CbGpPWpGaD
Dicoumarol—NQO1—Oxidative Stress—GPX1—Parkinson's disease	0.00105	0.0147	CbGpPWpGaD
Dicoumarol—NQO1—Amino acid and derivative metabolism—MCCC1—Parkinson's disease	0.00105	0.0147	CbGpPWpGaD
Dicoumarol—NQO1—head—Parkinson's disease	0.00101	0.0133	CbGeAlD
Dicoumarol—NQO1—nervous system—Parkinson's disease	0.00096	0.0126	CbGeAlD
Dicoumarol—NQO1—central nervous system—Parkinson's disease	0.000924	0.0122	CbGeAlD
Dicoumarol—NQO1—Transcriptional activation by NRF2—MAPK8—Parkinson's disease	0.000922	0.0129	CbGpPWpGaD
Dicoumarol—NQO1—cerebellum—Parkinson's disease	0.000903	0.0119	CbGeAlD
Dicoumarol—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—Parkinson's disease	0.000848	0.0118	CbGpPWpGaD
Dicoumarol—NQO1—Amino acid and derivative metabolism—DBH—Parkinson's disease	0.000797	0.0111	CbGpPWpGaD
Dicoumarol—CYP2C9—CYP2E1 reactions—CYP2D6—Parkinson's disease	0.000783	0.0109	CbGpPWpGaD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—ABL1—Parkinson's disease	0.000743	0.0104	CbGpPWpGaD
Dicoumarol—NQO1—brain—Parkinson's disease	0.000734	0.00965	CbGeAlD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—ABL1—Parkinson's disease	0.000732	0.0102	CbGpPWpGaD
Dicoumarol—CYP2C9—CYP2E1 reactions—CYP2E1—Parkinson's disease	0.000716	0.00999	CbGpPWpGaD
Dicoumarol—CYP2C9—cardiovascular system—Parkinson's disease	0.000714	0.0094	CbGeAlD
Dicoumarol—NQO1—NRF2 pathway—GSTA4—Parkinson's disease	0.000676	0.00944	CbGpPWpGaD
Dicoumarol—NQO1—Amino acid and derivative metabolism—DDC—Parkinson's disease	0.000585	0.00816	CbGpPWpGaD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—APOE—Parkinson's disease	0.000575	0.00802	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—HSPA9—Parkinson's disease	0.000555	0.00774	CbGpPWpGaD
Dicoumarol—CYP2C9—Xenobiotics—CYP2D6—Parkinson's disease	0.000485	0.00677	CbGpPWpGaD
Dicoumarol—CYP2C9—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.000467	0.00651	CbGpPWpGaD
Dicoumarol—CYP2C9—Xenobiotics—CYP2E1—Parkinson's disease	0.000444	0.00619	CbGpPWpGaD
Dicoumarol—CYP2C9—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000427	0.00596	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	0.00041	0.00573	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—HSPA1A—Parkinson's disease	0.000402	0.00561	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—SLC6A3—Parkinson's disease	0.000399	0.00557	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—RPL6—Parkinson's disease	0.000395	0.00552	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—ATP6AP2—Parkinson's disease	0.000375	0.00523	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—DCTN1—Parkinson's disease	0.000343	0.00478	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—GSTP1—Parkinson's disease	0.000338	0.00472	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—HMOX1—Parkinson's disease	0.000333	0.00465	CbGpPWpGaD
Dicoumarol—NQO1—Amino acid and derivative metabolism—TH—Parkinson's disease	0.000326	0.00455	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—HGF—Parkinson's disease	0.000311	0.00433	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—GSTM1—Parkinson's disease	0.000311	0.00433	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—RPL23A—Parkinson's disease	0.0003	0.00418	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—RPL14—Parkinson's disease	0.0003	0.00418	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	0.000298	0.00416	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	0.000298	0.00416	CbGpPWpGaD
Dicoumarol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.00029	0.00405	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—RPS8—Parkinson's disease	0.000279	0.0039	CbGpPWpGaD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—Parkinson's disease	0.000266	0.00371	CbGpPWpGaD
Dicoumarol—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000238	0.00332	CbGpPWpGaD
Dicoumarol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000227	0.00316	CbGpPWpGaD
Dicoumarol—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00022	0.00307	CbGpPWpGaD
Dicoumarol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000202	0.00281	CbGpPWpGaD
Dicoumarol—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000199	0.00277	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—ND3—Parkinson's disease	0.000193	0.0027	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—MCCC1—Parkinson's disease	0.000193	0.0027	CbGpPWpGaD
Dicoumarol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000184	0.00257	CbGpPWpGaD
Dicoumarol—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000182	0.00254	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—TALDO1—Parkinson's disease	0.000182	0.00253	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—OMD—Parkinson's disease	0.000182	0.00253	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—NDUFB11—Parkinson's disease	0.000172	0.0024	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—IGF2—Parkinson's disease	0.000167	0.00233	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—GCH1—Parkinson's disease	0.000164	0.00229	CbGpPWpGaD
Dicoumarol—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000163	0.00228	CbGpPWpGaD
Dicoumarol—CYP2C9—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.000155	0.00216	CbGpPWpGaD
Dicoumarol—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000149	0.00208	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—GBA—Parkinson's disease	0.000146	0.00204	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—FBP1—Parkinson's disease	0.000146	0.00204	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—DBH—Parkinson's disease	0.000146	0.00204	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—GSTA4—Parkinson's disease	0.000131	0.00183	CbGpPWpGaD
Dicoumarol—CYP2C9—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000129	0.0018	CbGpPWpGaD
Dicoumarol—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000123	0.00172	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—MAOB—Parkinson's disease	0.000117	0.00163	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—INS—Parkinson's disease	0.000111	0.00154	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—DDC—Parkinson's disease	0.000107	0.0015	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—GSTA4—Parkinson's disease	0.000101	0.00142	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—PLA2G6—Parkinson's disease	9.14e-05	0.00127	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—MAOB—Parkinson's disease	9.04e-05	0.00126	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—CYP2D6—Parkinson's disease	8.68e-05	0.00121	CbGpPWpGaD
Dicoumarol—CYP2C9—Metapathway biotransformation—CYP2D6—Parkinson's disease	8.56e-05	0.00119	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	7.94e-05	0.00111	CbGpPWpGaD
Dicoumarol—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	7.83e-05	0.00109	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	7.26e-05	0.00101	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—CYP2D6—Parkinson's disease	6.72e-05	0.000938	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—CTGF—Parkinson's disease	6.6e-05	0.000921	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—COMT—Parkinson's disease	6.58e-05	0.000918	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	6.54e-05	0.000913	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	6.53e-05	0.000911	CbGpPWpGaD
Dicoumarol—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	6.49e-05	0.000905	CbGpPWpGaD
Dicoumarol—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	6.46e-05	0.000901	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—CYP2E1—Parkinson's disease	6.15e-05	0.000858	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	6.01e-05	0.000839	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—TH—Parkinson's disease	5.99e-05	0.000836	CbGpPWpGaD
Dicoumarol—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	5.93e-05	0.000828	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—CYCS—Parkinson's disease	5.75e-05	0.000803	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—COMT—Parkinson's disease	5.09e-05	0.000711	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—GSTP1—Parkinson's disease	5.07e-05	0.000707	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—MAOA—Parkinson's disease	5.06e-05	0.000706	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—HMOX1—Parkinson's disease	5e-05	0.000698	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—ABCB1—Parkinson's disease	4.8e-05	0.00067	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—GSTM1—Parkinson's disease	4.66e-05	0.00065	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	4.53e-05	0.000632	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—GPX1—Parkinson's disease	4.46e-05	0.000623	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—ND3—Parkinson's disease	4.26e-05	0.000595	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—MCCC1—Parkinson's disease	4.26e-05	0.000595	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—MTHFR—Parkinson's disease	4.12e-05	0.000575	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—TALDO1—Parkinson's disease	4.01e-05	0.000559	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—OMD—Parkinson's disease	4.01e-05	0.000559	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—APOE—Parkinson's disease	3.83e-05	0.000535	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	3.8e-05	0.00053	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—GCH1—Parkinson's disease	3.63e-05	0.000506	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—INS—Parkinson's disease	3.27e-05	0.000457	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	3.27e-05	0.000456	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—FBP1—Parkinson's disease	3.23e-05	0.000451	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—DBH—Parkinson's disease	3.23e-05	0.000451	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—GBA—Parkinson's disease	3.23e-05	0.000451	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—DDC—Parkinson's disease	2.37e-05	0.000331	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—GSTA4—Parkinson's disease	2.24e-05	0.000313	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.21e-05	0.000309	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	2.02e-05	0.000281	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—MAOB—Parkinson's disease	2e-05	0.000279	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.9e-05	0.000265	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	1.48e-05	0.000207	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—CTGF—Parkinson's disease	1.46e-05	0.000203	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	1.36e-05	0.000189	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—NQO1—Parkinson's disease	1.34e-05	0.000187	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—TH—Parkinson's disease	1.32e-05	0.000185	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—CYCS—Parkinson's disease	1.27e-05	0.000177	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—COMT—Parkinson's disease	1.12e-05	0.000157	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—GSTP1—Parkinson's disease	1.12e-05	0.000156	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—MAOA—Parkinson's disease	1.12e-05	0.000156	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—HMOX1—Parkinson's disease	1.1e-05	0.000154	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—ABCB1—Parkinson's disease	1.06e-05	0.000148	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—GSTM1—Parkinson's disease	1.03e-05	0.000144	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—GPX1—Parkinson's disease	9.85e-06	0.000137	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—MTHFR—Parkinson's disease	9.09e-06	0.000127	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—APOE—Parkinson's disease	8.46e-06	0.000118	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—INS—Parkinson's disease	7.23e-06	0.000101	CbGpPWpGaD
